---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-020135"
form_type: "8-K"
ticker: "SFES"
cik: "0000086115"
company_name: "SAFEGUARD SCIENTIFICS INC"
filed_at: "2022-08-11T23:59:59+00:00"
generated_at: "2026-06-24T01:14:31.102927+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Safeguard Scientifics reports Q2 net income of $0.5M; Moxe dilution gain; exploring strategic alternatives

## Summary
- Net income of $0.5M ($0.03/diluted EPS) vs net loss of $0.3M ($0.02 loss/share) in Q2 2021.
- Moxe raised $30M equity, diluting Safeguard's ownership to 19.4%, generating a $5.3M non-cash dilution gain.
- Repurchased 221,479 shares in Q2 at avg $4.27, totaling $0.9M; remaining authorization $1.1M.
- Continues working with Houlihan Lokey to explore strategic alternatives to maximize shareholder value.
- Expects 2022 corporate expenses at low-end or below $3.5-4.0M; deployments may hit upper half of $5-9M range.

## SEC filing metadata
- accession: 0001437749-22-020135
- form_type: 8-K
- ticker: SFES
- cik: 0000086115
- company_name: SAFEGUARD SCIENTIFICS INC
- filed_at: 2022-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/86115/000143774922020135/0001437749-22-020135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/86115/000143774922020135/sfe20220525_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-020135
- JSON: https://secwatch.observer/filing/0001437749-22-020135.json
- Plain text: https://secwatch.observer/filing/0001437749-22-020135.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.